Kiromic Biopharma, Inc. Operating Lease Right-of-Use Assets
Kiromic Biopharma, Inc. had Operating Lease Right-of-Use Assets of $913.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-02-14
- 2024-12-31: Operating Lease, Right-of-Use Asset $913.00K.
- 2024-09-30: Operating Lease, Right-of-Use Asset $1.07M.
- 2024-06-30: Operating Lease, Right-of-Use Asset $1.23M.
- 2024-03-31: Operating Lease, Right-of-Use Asset $1.39M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2024-12-31 | $913.00K 10-K · filed 2025-02-14 | |
| 2024-09-30 | $1.07M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.23M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $1.39M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.54M 10-K · filed 2025-02-14 | $1.54M 10-K · filed 2024-03-19 |
| 2023-09-30 | $1.69M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.84M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.99M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.12M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $2.16M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.30M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.23M 10-Q · filed 2022-05-13 |